Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K
Division of Cardiology, Kumamoto University Medical School, Japan.
Circulation. 1989 Dec;80(6):1617-26. doi: 10.1161/01.cir.80.6.1617.
Plasma levels of fibrinopeptide A (FPA), beta-thromboglobulin (BTG), and platelet factor 4 (PF4) were examined on venous plasma samples taken every 4 hours for 24 hours in 20 patients with variant angina and 20 patients with stable exertional angina together with 24-hour Holter recordings. The mean plasma FPA levels (ng/ml) at 2:00 PM, 6:00 PM, 10:00 PM, 2:00 AM, 6:00 AM, and 10:00 AM were 4.6 +/- 1.0, 3.1 +/- 0.5, 6.1 +/- 1.6, 9.9 +/- 2.4, 8.7 +/- 1.4, and 4.2 +/- 0.8 in patients with variant angina (p less than 0.01) and 1.8 +/- 0.2, 2.3 +/- 0.3, 1.9 +/- 0.3, and 2.3 +/- 0.2 in those with stable exertional angina. In seven patients with variant angina, we also examined the effects of heparin (3,000 units), given subcutaneously at 6:00 PM, 10:00 PM, and 2:00 AM, on the plasma FPA levels and the anginal attacks. Although heparin suppressed the elevation and circadian variation of plasma FPA levels, it did not suppress the attacks and their circadian variation in these patients. Plasma FPA levels increased significantly from 3.7 +/- 0.5 to 12.5 +/- 2.7 ng/ml during or immediately after an attack in the seven patients with no heparin. On the other hand, the plasma levels of BTG and PF4 were increased in patients with variant angina as compared with those with stable exertional angina but did not show a significant circadian variation in both groups. We conclude that 1) plasma levels of FPA, BTG, and PF4 were increased in patients with variant angina as compared with those with stable exertional angina; 2) there was a significant circadian variation in the plasma levels of FPA in parallel with that of the frequency of the attacks with the peak level occurring from midnight to early morning in patients with variant angina; and 3) elevated levels of plasma FPA are the result and not the cause of coronary spasm.
对20例变异型心绞痛患者和20例稳定劳力型心绞痛患者,每4小时采集一次静脉血浆样本,共采集24小时,并进行24小时动态心电图记录,检测血浆纤维蛋白肽A(FPA)、β-血小板球蛋白(BTG)和血小板因子4(PF4)水平。变异型心绞痛患者下午2点、下午6点、晚上10点、凌晨2点、早上6点和早上10点的平均血浆FPA水平(ng/ml)分别为4.6±1.0、3.1±0.5、6.1±1.6、9.9±2.4、8.7±1.4和4.2±0.8(p<0.01),稳定劳力型心绞痛患者分别为1.8±0.2、2.3±0.3、1.9±0.3和2.3±0.2。在7例变异型心绞痛患者中,我们还研究了下午6点、晚上10点和凌晨2点皮下注射肝素(3000单位)对血浆FPA水平和心绞痛发作的影响。尽管肝素抑制了血浆FPA水平的升高和昼夜变化,但并未抑制这些患者的发作及其昼夜变化。7例未使用肝素的患者在发作期间或发作后,血浆FPA水平从3.7±0.5显著升高至12.5±2.7 ng/ml。另一方面,与稳定劳力型心绞痛患者相比,变异型心绞痛患者的血浆BTG和PF4水平升高,但两组均未显示出显著的昼夜变化。我们得出结论:1)与稳定劳力型心绞痛患者相比,变异型心绞痛患者血浆FPA、BTG和PF4水平升高;2)变异型心绞痛患者血浆FPA水平存在显著的昼夜变化,与发作频率平行,峰值出现在午夜至清晨;3)血浆FPA水平升高是冠状动脉痉挛的结果而非原因。